These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 39046746)

  • 1. Serious Opioid Injection-Related Infection and Initiation of Medication for Opioid Use Disorder.
    Springer SA
    JAMA Netw Open; 2024 Jul; 7(7):e2421640. PubMed ID: 39046746
    [No Abstract]   [Full Text] [Related]  

  • 2. Putting Parity into Practice - Integrating Opioid-Use Disorder Treatment into the Hospital Setting.
    Fanucchi L; Lofwall MR
    N Engl J Med; 2016 Sep; 375(9):811-3. PubMed ID: 27579631
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of opioid-agonist treatments on HIV risk and social stability: A mixed methods study of women with opioid use disorder in Ukraine.
    Hoff E; Marcus R; Bojko MJ; Makarenko I; Mazhnaya A; Altice FL; Meyer JP
    J Subst Abuse Treat; 2017 Dec; 83():36-44. PubMed ID: 29129194
    [No Abstract]   [Full Text] [Related]  

  • 4. The Impact of Medications for Opioid Use Disorder on Hepatitis C Incidence Among Incarcerated Persons: A Systematic Review.
    Seval N; Wurcel A; Gunderson CG; Grimshaw A; Springer SA
    Infect Dis Clin North Am; 2020 Sep; 34(3):559-584. PubMed ID: 32782102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of buprenorphine and methadone among opioid users who inject drugs.
    Tsui JI; Burt R; Thiede H; Glick SN
    Subst Abus; 2018 Jan; 39(1):83-88. PubMed ID: 28796591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Puffy hand syndrome.
    Vivaldelli E; Sansone S; Maier A; Wiedermann CJ
    Lancet; 2017 Jan; 389(10066):298. PubMed ID: 27524395
    [No Abstract]   [Full Text] [Related]  

  • 7. Alternate routes of administration and risk for HIV among prescription opioid abusers.
    Surratt H; Kurtz SP; Cicero TJ
    J Addict Dis; 2011 Oct; 30(4):334-41. PubMed ID: 22026525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal naloxone for treatment of opioid overdose.
    Med Lett Drugs Ther; 2014 Mar; 56(1438):21-2. PubMed ID: 24662159
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis C Virus Reinfection Rate Among Persons Who Use Drugs and Are Maintained on Medication Treatment for Opioid Use Disorder.
    Springer SA
    Clin Infect Dis; 2020 Jun; 70(12):2703-2705. PubMed ID: 31346595
    [No Abstract]   [Full Text] [Related]  

  • 10. "Clues" That Patients May Be Willing to Consider Opioid Reductions.
    Becker WC
    J Gen Intern Med; 2020 Jun; 35(6):1629-1630. PubMed ID: 32221855
    [No Abstract]   [Full Text] [Related]  

  • 11. Image Gallery: Nicolau syndrome after misuse of buprenorphine.
    Espitia O; Vigneau-Victorri C; Pistorius MA
    Br J Dermatol; 2017 Apr; 176(4):e35. PubMed ID: 28418123
    [No Abstract]   [Full Text] [Related]  

  • 12. Opioid initiation and injection transition in rural northern New England: A mixed-methods approach.
    Nolte K; Drew AL; Friedmann PD; Romo E; Kinney LM; Stopka TJ
    Drug Alcohol Depend; 2020 Dec; 217():108256. PubMed ID: 32947174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gabapentin and opioid craving.
    Tay KH
    Pain Med; 2009; 10(4):774. PubMed ID: 19453959
    [No Abstract]   [Full Text] [Related]  

  • 14. Trends in prescribed opioid therapy for non-cancer pain for individuals with prior substance use disorders.
    Weisner CM; Campbell CI; Ray TG; Saunders K; Merrill JO; Banta-Green C; Sullivan MD; Silverberg MJ; Mertens JR; Boudreau D; Von Korff M
    Pain; 2009 Oct; 145(3):287-293. PubMed ID: 19581051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C in Injection-Drug Users - A Hidden Danger of the Opioid Epidemic.
    Liang TJ; Ward JW
    N Engl J Med; 2018 Mar; 378(13):1169-1171. PubMed ID: 29601263
    [No Abstract]   [Full Text] [Related]  

  • 16. Prescription opioid treatment for non-cancer pain and initiation of injection drug use: large retrospective cohort study.
    Wilton J; Abdia Y; Chong M; Karim ME; Wong S; MacInnes A; Balshaw R; Zhao B; Gomes T; Yu A; Alvarez M; Dart RC; Krajden M; Buxton JA; Janjua NZ; Purssell R
    BMJ; 2021 Nov; 375():e066965. PubMed ID: 34794949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of substance use disorders in experiencing a repeat opioid overdose, and substance use treatment patterns among patients with a non-fatal opioid overdose.
    Karmali RN; Ray GT; Rubinstein AL; Sterling SA; Weisner CM; Campbell CI
    Drug Alcohol Depend; 2020 Apr; 209():107923. PubMed ID: 32126455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unequal access to opioid agonist treatment and sterile injecting equipment among hospitalized patients with injection drug use-associated infective endocarditis.
    Brothers TD; Mosseler K; Kirkland S; Melanson P; Barrett L; Webster D
    PLoS One; 2022; 17(1):e0263156. PubMed ID: 35081174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid Neurotoxicity Treated with Intrathecal Drug Delivery System Implant.
    Pittelkow TP; Wu KL; Strand JJ; Moeschler SM
    J Palliat Med; 2018 Feb; 21(2):126. PubMed ID: 29112460
    [No Abstract]   [Full Text] [Related]  

  • 20. Opioid withdrawal symptoms, frequency, and pain characteristics as correlates of health risk among people who inject drugs.
    Bluthenthal RN; Simpson K; Ceasar RC; Zhao J; Wenger L; Kral AH
    Drug Alcohol Depend; 2020 Jun; 211():107932. PubMed ID: 32199668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.